LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.003
 6.94 771.67 1019 1045 0.9750 0.8876
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 6.94 771.67 1027 1045 0.9827 0.9216
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 6.94 771.67 1064 1045 1.0181 1.0835
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 9.16 771.67 1119 1138 0.9829 0.9394
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 9.16 771.67 1104 1138 0.9697 0.8933
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 9.16 771.67 1169 1138 1.0268 1.0965
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 11.56 771.67 1221 1280 0.9534 0.8737
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 11.56 771.67 1251 1280 0.9769 0.9370
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 11.56 771.67 1290 1280 1.0073 1.0201
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 13.78 771.67 1411 1459 0.9666 0.9275
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 13.78 771.67 1381 1459 0.9461 0.8830
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 13.78 771.67 1468 1459 1.0057 1.0123
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 16.00 771.67 1555 1585 0.9808 0.9630
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 16.00 771.67 1556 1585 0.9814 0.9642
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 16.00 771.67 1621 1585 1.0224 1.0431
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 18.22 771.67 1614 1741 0.9269 0.8747
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 18.22 771.67 1635 1741 0.9389 0.8955
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 18.22 771.67 1737 1741 0.9975 0.9957
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 20.44 771.67 1667 1910 0.8724 0.8018
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 20.44 771.67 1713 1910 0.8965 0.8397
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 20.44 771.67 1819 1910 0.9519 0.9261
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 22.66 771.67 1744 2141 0.8144 0.7397
MN20160304_L01
E20
MCF 10A-H2B-mCherry Trametinib
0.003
 22.66 771.67 1761 2141 0.8223 0.7512
MN20160304_L01
H05
MCF 10A-H2B-mCherry Trametinib
0.003
 22.66 771.67 1914 2141 0.8938 0.8531
MN20160304_L01
I21
MCF 10A-H2B-mCherry Trametinib
0.003
 24.89 771.67 1815 2397 0.7570 0.6869
MN20160304_L01
E20